BeOne Medicines AG Statistics
Total Valuation
ONC has a market cap or net worth of $31.12 billion. The enterprise value is $27.46 billion.
Important Dates
The next estimated earnings date is Wednesday, August 5, 2026, before market open.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ONC has 111.17 million shares outstanding. The number of shares has increased by 10.10% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 111.17M |
| Shares Change (YoY) | +10.10% |
| Shares Change (QoQ) | +1.13% |
| Owned by Insiders (%) | 4.45% |
| Owned by Institutions (%) | 50.79% |
| Float | 78.21M |
Valuation Ratios
The trailing PE ratio is 61.95 and the forward PE ratio is 39.39.
| PE Ratio | 61.95 |
| Forward PE | 39.39 |
| PS Ratio | 5.45 |
| Forward PS | 0.67 |
| PB Ratio | 6.49 |
| P/TBV Ratio | 6.75 |
| P/FCF Ratio | 26.01 |
| P/OCF Ratio | 23.02 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 33.43, with an EV/FCF ratio of 22.96.
| EV / Earnings | 51.45 |
| EV / Sales | 4.81 |
| EV / EBITDA | 33.43 |
| EV / EBIT | 40.17 |
| EV / FCF | 22.96 |
Financial Position
The company has a current ratio of 3.73, with a Debt / Equity ratio of 0.25.
| Current Ratio | 3.73 |
| Quick Ratio | 3.26 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | 1.40 |
| Debt / FCF | 1.00 |
| Interest Coverage | 11.74 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 37.33% |
| Return on Capital Employed (ROCE) | 10.07% |
| Weighted Average Cost of Capital (WACC) | 6.85% |
| Revenue Per Employee | $475,411 |
| Profits Per Employee | $44,478 |
| Employee Count | 12,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ONC has paid $124.18 million in taxes.
| Income Tax | 124.18M |
| Effective Tax Rate | 18.88% |
Stock Price Statistics
The stock price has increased by +4.82% in the last 52 weeks. The beta is 0.49, so ONC's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | +4.82% |
| 50-Day Moving Average | 291.96 |
| 200-Day Moving Average | 316.78 |
| Relative Strength Index (RSI) | 50.67 |
| Average Volume (20 Days) | 299,431 |
Short Selling Information
The latest short interest is 1.09 million, so 1.53% of the outstanding shares have been sold short.
| Short Interest | 1.09M |
| Short Previous Month | 1.05M |
| Short % of Shares Out | 1.53% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.65 |
Income Statement
In the last 12 months, ONC had revenue of $5.70 billion and earned $533.73 million in profits. Earnings per share was $4.52.
| Revenue | 5.70B |
| Gross Profit | 5.03B |
| Operating Income | 683.63M |
| Pretax Income | 657.92M |
| Net Income | 533.73M |
| EBITDA | 821.44M |
| EBIT | 683.63M |
| Earnings Per Share (EPS) | $4.52 |
Full Income StatementBalance Sheet
The company has $4.85 billion in cash and $1.19 billion in debt, giving a net cash position of $3.66 billion or $32.89 per share.
| Cash & Cash Equivalents | 4.85B |
| Total Debt | 1.19B |
| Net Cash | 3.66B |
| Net Cash Per Share | $32.89 |
| Equity (Book Value) | 4.79B |
| Book Value Per Share | 43.10 |
| Working Capital | 4.84B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.35 billion and capital expenditures -$172.69 million, giving a free cash flow of $1.20 billion.
| Operating Cash Flow | 1.35B |
| Capital Expenditures | -172.69M |
| Depreciation & Amortization | 139.82M |
| Net Borrowing | 158.92M |
| Free Cash Flow | 1.20B |
| FCF Per Share | $10.76 |
Full Cash Flow StatementMargins
Gross margin is 88.23%, with operating and profit margins of 11.98% and 9.36%.
| Gross Margin | 88.23% |
| Operating Margin | 11.98% |
| Pretax Margin | 11.53% |
| Profit Margin | 9.36% |
| EBITDA Margin | 14.40% |
| EBIT Margin | 11.98% |
| FCF Margin | 20.97% |